Effect of Central and Peripheral Injected Nesfatin-1 on Electrocardiography in Rats
Nesfatin-1 is an anorexic nucleobindin-2 -derived peptide and it has directly and centrally effect on the heart. The current study was designed
___
- 1. Oh-I S, Shimizu H, Satoh T, et al. Identification of nesfatin-
1 as a satiety molecule in the hypothalamus. Nature.
2006;12:709–712.
- 2. Brailoiu GC, Dun SL, Brailoiu E, et al. Nesfatin-1: distribution
and interaction with a G protein-coupled receptor
in the rat brain. Endocrinology. 2007;148:5088–
5094.
- 3. Goebel M, Stengel A, Wang L, et al. Nesfatin-1 immunoreactivity
in rat brain and spinal cord autonomic
nuclei. Neurosci Lett. 2009;452:241–246.
- 4. Stengel A, Goebel M, Yakubov I, et al. Identification
and characterization of nesfatin-1 immunoreactivity
in endocrine cell types of the rat gastric oxyntic mucosa.
Endocrinology. 2009;150:232–238.
- 5. Angelone T, Filice E, Pasqua T, et al. Nesfatin-1 as a
novel cardiac peptide: identification, functional characterization,
and protection against ischemia/reperfusion
injury. Cell Mol Life Sci. 2013;70:495–509.
- 6. Garcia-Galiano D, Navarro VM, Gaytan F, et al. Expanding
roles of NUCB2/nesfatin-1 in neuroendocrine
regulation. J Mol Endocrinol. 2010;45:281–290.
- 7. Stengel A, Tache Y. Minireview: nesfatin-1--an emerging
new player in the brain-gut, endocrine, and metabolic
axis. Endocrinology. 2011;152:4033-4038.
- 8. Yilmaz MS, Altinbas B, Guvenc G, et al. The role of
centrally injected nesfatin-1 on cardiovascular regulation
in normotensive and hypotensive rats. Auton
Neurosci. 2015;193:63–68.
- 9. Aydin B, Guvenc G, Altinbas B, et al. Modulation of
nesfatin-1-induced cardiovascular effects by the central
cholinergic system. Neuropeptides. 2018;70:9-15.
- 10. Tanida M, Mori M. Nesfatin-1 stimulates renal sympathetic
nerve activity in rats. Neuroreport. 2011;20:309–
312.
- 11. Yosten GL, Samson WK. Nesfatin-1 exerts cardiovascular
actions in brain: possible interaction with the
central melanocortin system. Am J Phys Regul Integr
Comp Phys. 2009;297:330–336.
- 12. Mimee A, Smith PM, Ferguson AV. Nesfatin-1 influences
the excitability of neurons in the nucleus of the
solitary tract and regulates cardiovascular function.
Am J Phys Regul Integr Comp Phys. 2012;302:1297–
1304.
- 13. Yamawaki H, Takahashi M, Mukohda M, et al. A novel
adipocytokine, nesfatin-1 modulates peripheral arterial
contractility and blood pressure in rats. Biochem
Biophys Res Commun. 2012;24:676–681.
- 14. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates.
4th Ed. Academic Press, New York; 2005.
- 15. Hall JE. Cardiac Arrhythmias and their electrocardiographic
interpretation. In: Hall JE, Guyton AC,
Schmitt W, eds. Guyton and Hall Textbook of Medical
Physiology. 12th ed. Saunders, London; 2011:143-153.
- 16. Wagner GS, Macfarlane P, Wellens H, et al. AHA/
ACCF/HRS recommendations for the standardization
and interpretation of the electrocardiogram: part VI:
acute ischemia/infarction: a scientific statement from
the American Heart Association Electrocardiography
and Arrhythmias Committee, Council on Clinical
Cardiology; the American College of Cardiology
Foundation; and the Heart Rhythm Society. Endorsed
by the International Society for Computerized Electrocardiology.
J Am Coll Cardiol. 2009;53:1003-1011.
- 17. Brailoiu GC, Deliu E, Tica AA, et al. Nesfatin-1 activates
cardiac vagal neurons of nucleus ambiguous and
elicits bradycardia in conscious rats. J Neurochem.
2013;126:739–748.
- 18. Yosten GL, Samson WK. The anorexigenic and hypertensive
effects of nesfatin-1 are reversed by pretreatment
with an oxytocin receptor antagonist. Am J Phys
Regul Integr Comp Phys. 2010;298:1642–1647.
- 19. Yosten GL, Samson WK. Neural circuitry underlying
the central hypertensive action of nesfatin-1:
melanocortins, corticotropin-releasing hormone,
and oxytocin. Am J Phys Regul Integr Comp Phys.
2014;306:722–727.
- 20. Kohno D, Nakata M, Maejima Y, et al. Nesfatin-1 neurons
in paraventricular and supraoptic nuclei of the
rat hypothalamus coexpress oxytocin and vasopressin
and are activated by refeeding. Endocrinology.
2008;149:1295–1301.